Q/C Technologies, Inc. Unrealized Gain on Securities
Q/C Technologies, Inc. (QCLS) reported Unrealized Gain on Securities of $201.90 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainOnSecurities · last filed 2020-08-14
- Q/C Technologies, Inc. unrealized gain on securities for the quarter ending 2020-06-30 was $201.90K, a 1017.99% increase year-over-year.
- Q/C Technologies, Inc. unrealized gain on securities for the quarter ending 2020-03-31 was $29.34K, a 0.00% change year-over-year.
- Q/C Technologies, Inc. unrealized gain on securities for the quarter ending 2019-12-31 was -$1.80K.
- Q/C Technologies, Inc. unrealized gain on securities for the quarter ending 2019-09-30 was $45.60K.
- Q/C Technologies, Inc. unrealized gain on securities for fiscal 2019 was $43.80K.
| Period end | Unrealized Gain on Securities 3 month | Unrealized Gain on Securities 6 month | Unrealized Gain on Securities 9 month | Unrealized Gain on Securities 12 month |
|---|---|---|---|---|
| 2020-06-30 | $201.90K 10-Q · filed 2020-08-14 | $231.24K derived: sum of 2 quarters · filed 2020-08-14 | $229.44K derived: sum of 3 quarters · filed 2020-08-14 | $275.04K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $29.34K 10-Q · filed 2020-05-15 | $27.55K derived: sum of 2 quarters · filed 2020-05-15 | $73.14K derived: sum of 3 quarters · filed 2020-05-15 | $91.20K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | -$1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $43.80K derived: sum of 2 quarters · filed 2020-03-25 | $61.86K derived: sum of 3 quarters · filed 2020-08-14 | $43.80K 10-K · filed 2020-03-25 |
| 2019-09-30 | $45.60K 10-Q · filed 2019-11-14 | $63.66K derived: sum of 2 quarters · filed 2020-08-14 | $45.60K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $18.06K 10-Q · filed 2020-08-14 | $47.40K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $29.34K 10-Q · filed 2020-05-15 | |||
| 2018-06-30 | $852.00 10-Q · filed 2018-08-14 | $1.01K 10-Q · filed 2018-08-14 | ||
| 2017-09-30 | $1.90K 10-Q · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |